Skip to main content

Advertisement

Log in

Neurological grading, survival, MR imaging, and histological evaluation in the rat brainstem glioma model

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Objective

Convection-enhanced delivery using carboplatin in brainstem glioma models was reported to prolong survival. Functional impairment is of additional importance to evaluate the value of local chemotherapy. We established a neurological scoring system for the rat brainstem glioma model.

Material and methods

In 46 male Fisher rats stereotactically 105 F-98 cells were implanted at 1.4-mm lateral to midline and at the lambdoid suture using guided screws. Following 4 days local delivery was performed using AlzetTM pumps (1 μl/h over 7 days) with either vehicle (5% dextrose) or carboplatin via one or two cannulas, respectively. All rats were subsequently tested neurologically using a specified neurological score. In 38 animals survival time was recorded. Representative MR imaging were acquired in eight rats, respectively, at day 12 after implantation. HE staining was used to evaluate tumor extension.

Results

Neurological scoring showed significantly higher impairment in the high dose carboplatin group during the treatment period. Survival was significantly prolonged compared to control animals in the high dose carboplatin-one cannula group as well as in both low dose carboplatin groups (18.6 ± 3 versus 26.3 ± 9, 22.8 ± 2, 23.6 ± 2 days; p < 0.05). Overall neurological grading correlated with survival time. MR imaging showed a focal contrast enhancing mass in the pontine brainstem, which was less exaggerated after local chemotherapy. Histological slices visualized decreased cellular density in treatment animals versus controls.

Conclusion

Local chemotherapy in the brainstem glioma model showed significant efficacy for histological changes and survival. Our neurological grading enables quantification of drug and tumor-related morbidity as an important factor for functional performance during therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H (2008) Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol 15(10):2887–2893

    Article  PubMed  Google Scholar 

  2. Barth RF (1998) Rat brain tumor models in experimental neurooncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36:91–102

    Article  CAS  PubMed  Google Scholar 

  3. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17(3):472–476

    CAS  PubMed  Google Scholar 

  4. Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, Luporsi E, Margueritte G, Lejars O, Laithier V, Mechinaud F, Millot F, Kalifa C, Chastagner P (2005) Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer 104(12):2792–2797

    Article  CAS  PubMed  Google Scholar 

  5. Brem S, Tyler B, Li K, Pradilla G, Legnani F, Caplan J, Brem H (2007) Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother Pharmacol 60(5):643–650

    Article  CAS  PubMed  Google Scholar 

  6. Carson BS Sr, Wu Q, Tyler B, Sukay L, Raychaudhuri R, DiMeco F, Clatterbuck RE, Olivi A, Guarnieri M (2002) New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery. J Neurooncol 60(2):151–158

    Article  PubMed  Google Scholar 

  7. Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, Lonser RR (2003) Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 99(5):893–898

    Article  CAS  PubMed  Google Scholar 

  8. Dunn IF, Black PM (2003) The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy. Neurosurgery 52(6):1411–1422

    Article  PubMed  Google Scholar 

  9. Epstein F, Wisoff JH (1988) Intrinsic brainstem tumors in childhood, surgical indications. J Neurooncol 6:309–317

    Article  CAS  PubMed  Google Scholar 

  10. Ferguson SD, Foster K, Yamini B (2007) Convection-enhanced delivery for treatment of brain tumors. Expert Rev Anticancer Ther 7(12 Suppl):79–85

    Article  Google Scholar 

  11. Fernández-Hidalgo OA, Vanaclocha V, Vieitez JM, Aristu JJ, Rebollo J, Gúrpide A, Aramendía JM, Moreno-Palanques R, Martín-Algarra S, Subirá ML, Brugarolas A (1996) High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients. Bone Marrow Transplant 18(1):143–149

    PubMed  Google Scholar 

  12. Freeman CR, Krischer J, Sanford RA, Burger PC, Cohen M, Norris D (1988) Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 15:311–318

    Article  CAS  PubMed  Google Scholar 

  13. Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE (1993) Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 30;27(2):197–206

    Google Scholar 

  14. Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D, Neuwelt EA (2006) Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. J Neurooncol 77(3):279–284

    Article  CAS  PubMed  Google Scholar 

  15. Hashizume R, Ozawa T, Gryaznov SM, Bollen AW, Lamborn KR, Frey WH 2nd, Deen DF (2008) New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol 10(2):112–120

    Article  CAS  PubMed  Google Scholar 

  16. Jallo GI, Becker M, Liu YJ, Carson BS Sr, Guarnieri M (2006) Local infusion therapy in the monkey brainstem: technical considerations. Surg Technol Int 15:311–316

    PubMed  Google Scholar 

  17. Jallo GI, Volkov A, Wong C, Carson BS Sr, Penno MB (2006) A novel brainstem tumor model: functional and histopathological characterization. Childs Nerv Syst 22(12):1519–1525

    Article  PubMed  Google Scholar 

  18. Jallo GI (2006) Brainstem gliomas. Childs Nerv Syst 22(1):1–2

    Article  PubMed  Google Scholar 

  19. Kunwar S (2003) Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. Acta Neurochir Suppl 88:105–111

    CAS  PubMed  Google Scholar 

  20. Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, Hadani M, Ram Z (2004) Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 100(3):472–479

    Article  CAS  PubMed  Google Scholar 

  21. Lonser RR, Warren KE, Butman JA, Quezado Z, Robison RA, Walbridge S, Schiffman R, Merrill M, Walker ML, Park DM, Croteau D, Brady RO, Oldfield EH (2007) Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg 107(1):190–197

    Article  PubMed  Google Scholar 

  22. Murad GJ, Walbridge S, Morrison PF, Garmestani K, Degen JW, Brechbiel MW, Oldfield EH, Lonser RR (2006) Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res 12(10):3145–3151

    Article  CAS  PubMed  Google Scholar 

  23. Pöpperl G, Goldbrunner R, Gildehaus FJ, Kreth FW, Tanner P, Holtmannspötter M, Tonn JC, Tatsch K (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 32(9):1018–1025

    Article  PubMed  CAS  Google Scholar 

  24. Rousseau J, Boudou C, Barth RF, Balosso J, Estève F, Elleaume H (2007) Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 13(17):5195–5201

    Article  CAS  PubMed  Google Scholar 

  25. Sandberg DI, Edgar MA, Souweidane MM (2002) Convection-enhanced delivery into the rat brainstem. J Neurosurg 96(5):885–891

    Article  PubMed  Google Scholar 

  26. Souweidane MM, Occhiogrosso G, Mark EB, Edgar MA, Dunkel IJ (2004) Interstitial infusion of carmustine in the rat brain stem with systemic administration of O6-benzylguanine. J Neurooncol 67(3):319–326

    Article  PubMed  Google Scholar 

  27. Strege RJ, Liu YJ, Kiely A, Johnson RM, Gillis EM, Storm P, Carson BS, Jallo GI, Guarnieri M (2004) Toxicity and cerebrospinal fluid levels of carboplatin chronically infused into the brainstem of a primate. J Neurooncol 67(3):327–334

    Article  CAS  PubMed  Google Scholar 

  28. Thomale UW, Tyler B, Renard VM, Dorfman B, Guarnieri M, Haberl HE, Jallo GI (2008) Local chemotherapy in the rat brainstem with multiple catheters: a feasibility study. Childs Nerv Syst 9 (in press)

  29. Vogelbaum MA, Sampson JH, Kunwar S, Chang SM, Shaffrey M, Asher AL, Lang FF, Croteau D, Parker K, Grahn AY, Sherman JW, Husain SR, Puri RK (2007) Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery 61(5):1031–1037

    Article  PubMed  Google Scholar 

  30. Wagner S, Warmuth-Metz M, Emser A, Gnekow AK, Sträter R, Rutkowski S, Jorch N, Schmid HJ, Berthold F, Graf N, Kortmann RD, Pietsch T, Sörensen N, Peters O, Wolff JE (2006) Treatment options in childhood pontine gliomas. J Neurooncol 79(3):281–287

    Article  PubMed  Google Scholar 

  31. Walker DA, Punt JA, Sokal M (1999) Clinical management of brainstem glioma. Arch Dis Child 80:558–567

    Article  CAS  PubMed  Google Scholar 

  32. Wechsler H, Ramadan MA, Pfeiffer SE (1979) Morphologic and biochemical characteristics of transplantable neurogenic tumors induced by N-ethyl-N-nitrosourea in inbred BD IX rats. J Natl Cancer Inst 62:811–817

    CAS  PubMed  Google Scholar 

  33. Westphal M, Ram Z, Riddle V, Hilt D, Bortey E (2006) Executive Committee of the Gliadel Study Group. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir 148(3):269–275

    Article  CAS  Google Scholar 

  34. Zausinger S, Hungerhuber E, Baethmann A, Reulen H, Schmid-Elsaesser R (2000) Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res 863(1–2):94–105

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. W. Thomale.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomale, U.W., Tyler, B., Renard, V. et al. Neurological grading, survival, MR imaging, and histological evaluation in the rat brainstem glioma model. Childs Nerv Syst 25, 433–441 (2009). https://doi.org/10.1007/s00381-008-0767-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-008-0767-5

Keywords

Navigation